Evolutionary Genomics, Inc.
FNAM · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -89.8% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -14,245.2% | -67.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -19,763.4% | -598.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -13,695.1% | -646.5% |
| EPS Diluted | -0.35 | -0.52 | -0.34 | -0.13 |
| % Growth | 32.7% | -52.9% | -161.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |